Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
With New Notification Scheme, Settlement Payout May Be Higher
AstraZeneca Pharmaceuticals has agreed to pay $103 million to settle the multidistrict litigation that claimed it and other drug companies inflated the published average wholesale prices that the government and other third-party payers use to set drug company reimbursement rates. The amounts it will actually pay to consumers are expected to be higher than in most similar past settlements because of a clause in the agreement that calls for the third-party payers, like insurance companies, to provide a settlement administrator with information about payments made by insurance policy holders. This will allow for notification to those eligible to make claims, rather than simply an unfocused public notification. Wells Wilkinson, director of the Prescription Access Litigation project at Community Catalyst Inc., which was involved in negotiating the claims administration process for the settlement, said, “Typically, one of the hardest things to do is to identify consumers who can participate in the settlement.” Jennifer Fountain Connolly, Of Counsel to the Washington office of the plaintiff's law firm Hagens Berman Sobol Shapiro, says a similar notification plan was used in the $350 million settlement of New England Carpenters Health Benefits Fund, et al. v. McKesson Corp., a case that also involved claims of inflation of average wholesale prices of drugs. “That was the first time we used the same mechanism, and it greatly increased the claims rate,” Connolly said. “It multiplies by several factors the number of consumers who make claims.”
FDA Fines Red Cross for Failing to Comply with Blood Safety Regulations
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.
How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.